Top compounds associated with response to MLYCD


Feature Type Standardized
Nominal ANOVA
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA MK-2206 CTRPv2 pan-cancer AAC 0.14 8e-05
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA Docetaxel gCSI pan-cancer AAC -0.19 0.0003
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA Zebularine CTRPv2 pan-cancer AAC -0.12 0.0003
mRNA lovastatin CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA paclitaxel gCSI pan-cancer AAC -0.17 0.0006
Download CSV